Clinical Outcome of Hypomethylating Agents in Hypocellular MDS: Mayo Clinic Experience

被引：0
|
作者：
Cerquozzi, Sonia [1 ]
Alkhateeb, Hassan B. [1 ]
Binder, Moritz [2 ]
Zblewski, Darci [1 ]
Hashmi, Shahrukh K. [1 ]
Patnaik, Mrinal M. [1 ]
Hogan, William J. [1 ]
Litzow, Mark R. [1 ]
Al-Kali, Aref [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Dept Internal Med, Rochester, MN USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Case series of hypomethylating agents (HMA) effect on myelodysplastic/myeloproliferative neoplasm unclassified (MDS/MPN-U): Mayo Clinic experience.
    Abou Hussein, Ahmed K.
    Patnaik, Mrinal Mahesh
    Zblewski, Darci
    Gangat, Naseema
    Hashmi, Shahrukh
    Elliott, Michelle A.
    Hogan, William J.
    Litzow, Mark Robert
    Al-Kali, Aref
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] HYPOMETHYLATING AGENTS ARE EFFECTIVE IN SHRINKING SPLENOMEGALY IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML): MAYO CLINIC EXPERIENCE
    Subari, S.
    Patnaik, M.
    Alfakara, D.
    Zblewski, D.
    Hook, C.
    Hashmi, S.
    Hogan, W.
    Litzow, M.
    Al-Kali, A.
    HAEMATOLOGICA, 2015, 100 : 489 - 489
  • [3] Use of revised International Prognostic Scoring System (IPSS-R) in hypocellular myelodysplastic syndromes (MDS): Mayo Clinic experience.
    Cerquozzi, Sonia
    Zblewski, Darci
    Begna, Kebede
    Alkhateeb, Hassan
    Schultz, Kirsten
    Chen, Dong
    Litzow, Mark Robert
    Al-Kali, Aref
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Clinical Characteristics and Outcome of Adult Acute Erythroleukemia; Mayo Clinic Experience
    Alkhateeb, Hassan B.
    Damlaj, Moussab
    Al-Kali, Aref
    Gangat, Naseema
    Hogan, William J.
    Elliott, Michelle
    Litzow, Mark R.
    Patnaik, Mrinal M.
    BLOOD, 2015, 126 (23)
  • [5] Effect of grade (G) 3 fibrosis on clinical outcome of patients (Pts) with myelodysplastic syndromes (MDS): Mayo Clinic Experience.
    Cheema, Naveed
    Baidoun, Firas
    Zblewski, Darci
    Hashmi, Shahrukh
    Gangat, Naseema
    Wolanskyj, Alexandra P.
    Hogan, William J.
    Litzow, Mark Robert
    Chen, Dong
    Al-Kali, Aref
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Hypomethylating agents and chemotherapy in MDS
    Ades, Lionel
    Santini, Valeria
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (04) : 411 - 419
  • [7] Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients
    Morsia, Erika
    McCullough, Kristen
    Joshi, Maansi
    Cook, Joselle
    Alkhateeb, Hassan B.
    Al-Kali, Aref
    Begna, Kebede
    Elliott, Michelle
    Hogan, William
    Litzow, Mark
    Shah, Mithun
    Pardanani, Animesh
    Patnaik, Mrinal
    Tefferi, Ayalew
    Gangat, Naseema
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (12) : 1511 - 1521
  • [8] Clinical Characteristics and Inciting Agents for Pseudoporphyria: The Mayo Clinic Experience, 1996-2020
    Kumar, Anagha Bangalore
    Asamoah, Eucabeth M.
    Wetter, David A.
    Davis, Mark Denis P.
    Alavi, Afsaneh
    ADVANCES IN SKIN & WOUND CARE, 2024, 37 (08) : 406 - 411
  • [9] USAGE OF HYPOMETHYLATING AGENTS IN CHILDREN WITH MDS
    Dishlevaya, Z.
    Arhipova, A.
    Purbueva, B.
    Fink, O.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S457 - S457
  • [10] The Significance and Clinical Outcome of Lymphocytic Duodenosis in Children: Mayo Clinic Experience and Systematic Review
    Devara, Janaki
    Alsawas, Mouaz
    Larson, Joseph J.
    Mounajjed, Taofic
    Murray, Joseph A.
    Absah, Imad
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 72 (02): : 288 - 293
12345